Finance
Sun Pharma Buys New Jersey-Based Organon in $12 Billion Deal
Sun Pharmaceutical Industries Ltd. has agreed to acquire New York-listed women’s health-care company Organon & Co., expanding its global reach with one of the biggest outbound deals by an Indian company.
B
Bloomberg
April 27, 2026·1 min read
Image: Bloomberg
Sun Pharmaceutical Industries Ltd. has agreed to acquire New York-listed women’s health-care company Organon & Co., expanding its global reach with one of the biggest outbound deals by an Indian company.
Original article
Sun Pharma Buys New Jersey-Based Organon in $12 Billion Deal
Published by Bloomberg